Co-reporter:Annika Gross, Hamed Alborzinia, Stefania Piantavigna, Lisandra L. Martin, Stefan Wölfl and Nils Metzler-Nolte
Metallomics 2015 vol. 7(Issue 2) pp:371-384
Publication Date(Web):22 Jan 2015
DOI:10.1039/C4MT00255E
Compounds which are able to destabilize the lysosomal membrane have been proposed as interesting candidates for targeted anticancer drugs due to the pronounced lysosomal changes in cancer cells. For this purpose, metallocene derivatives of a cell penetrating polyarginine peptide M–(Arg)9(Phe)2Lys–NH2 (where M = ferrocene carboxylate or ruthenocene carboxylate) were designed and their biological activities were investigated in detail. The ferrocenoyl- and ruthenocenoyl polyarginine bioconjugates were synthesized via Fmoc solid-phase peptide synthesis (SPPS) protocols on a microwave-assisted synthesizer. After HPLC purification >98% purity was observed for all conjugates. Their interaction with supported biomimetic membranes was investigated on a quartz crystal microbalance (QCM) and revealed a very strong binding of the metallocene peptides and their metal-free congeners to an artificial eukaryotic membrane model (DMPC–cholesterol). To demonstrate their antiproliferative utility as cytotoxic compounds for a targeted anticancer drug, cell viability (by the crystal violet assay), apoptosis (flow cytometry, Ann V/PI staining), induction of reactive oxygen species (ROS, by flow cytometry with dihydroethidium staining), and changes in cancer cell metabolism, e.g. respiration and glycolysis, were studied. Our results reveal only a weak toxicity for the metal-free polyarginine peptide, which could be significantly enhanced (to ca. 50 μM against HeLa cells in the best case) by coupling ferrocene or ruthenocene carboxylates to the N-terminus of the peptide. The investigation of the cellular uptake and intracellular localization by fluorescence microscopy revealed an enhanced vesicular disruption by the metallocene bioconjugate compared to the metal-free derivative which could be triggered by light and chemicals. Further studies of apoptosis, respiration, glycolysis and ROS formation reveal the superior characteristics of the metallocene compounds. While most cells remain viable even at 300 μM of the metal free bioconjugate 1, most cells are dead or in late stages of apoptosis at 200 μM of the ruthenocene derivative 3, and at 100 μM of the most active ferrocene derivative 2, however, all show very little sign of necrosis. Also, the metal free compound 1 does not induce ROS formation but both metallocene–polyarginine bioconjugates are clearly associated with enhanced intracellular ROS levels, with levels for the redox-active ferrocene derivative being two times higher than for the structurally very similar but redox-silent ruthenocene derivative. We propose that such metallocene–polyarginine peptides induce lysosomal membrane permeabilization and thereby could be developed towards targeted anticancer drugs.
Co-reporter:Dr. Annika Gross;Daniel Habig ; Dr. Nils Metzler-Nolte
ChemBioChem 2013 Volume 14( Issue 18) pp:2472-2479
Publication Date(Web):
DOI:10.1002/cbic.201300450
Abstract
The chemically stabilized somatostatin-derived cyclic octapeptide octreotate has a number of interesting applications in medicinal chemistry. Here, a number of different organometallic derivatives of octreotate were prepared, and their properties were investigated. Specifically, we report the synthesis and characterization of ruthenocene, ferrocene, and cobaltocenium octreotate derivatives and their fluorophore-labeled conjugates as well as a dicobalt hexacarbonyl alkyne functionalized octreotate. To provide further insights into their characteristics, the log P values and electrochemical properties of the novel metal conjugates were compared. For biological activity, we determined their toxicity in three different cell lines. Cellular uptake and colocalization of selected compounds were studied by fluorescence microscopy with particular focus on efficiency and specificity of their uptake through the somatostatin receptor SSTR to elucidate the value of the metallocene head group for its potential use as a nontoxic and universal peptide label.
Co-reporter:Annika Gross, Nina Hüsken, Julia Schur, Łukasz Raszeja, Ingo Ott, and Nils Metzler-Nolte
Bioconjugate Chemistry 2012 Volume 23(Issue 9) pp:1764
Publication Date(Web):July 24, 2012
DOI:10.1021/bc200692g
Labeling of peptide nucleic acids (PNA) with metallocene complexes is explored herein for the modulation of the analytical characteristics, as well as biological properties of PNA. The synthesis of the first ruthenocene–PNA conjugate with a dodecamer, mixed-sequence PNA is described, and its properties are compared to a ferrocene-labeled analogue as well as an acetylated, metal-free derivative. The synthetic characteristics, chemical stability, analytical and thermodynamic properties, and the interaction with cDNA were investigated. Furthermore, the cytotoxicity of the PNA conjugates is determined on HeLa, HepG2, and PT45 cell lines. Finally, the cellular uptake of the metal-containing PNAs was quantified by high-resolution continuum source atomic absorption spectrometry (HR-CS AAS). An unexpectedly high cellular uptake to final concentrations of 4.2 mM was observed upon incubation with 50 μM solutions of the ruthenocene–PNA conjugate. The ruthenocene label was shown to be an excellent label in all respects, which is also more stable than its ferrocene analogue. Because of its high stability, low toxicity, and the lack of a natural background of ruthenium, it is an ideal choice for bioanalytical purposes and possible medicinal and biological applications like, e.g., the development of gene-targeted drugs.
Co-reporter:Dr. Nina Hüsken;Dr. Magdalena G&x119;bala;Alberto Battistel;Dr. Fabio La Mantia; Dr. Wolfgang Schuhmann; Dr. Nils Metzler-Nolte
ChemPhysChem 2012 Volume 13( Issue 1) pp:131-139
Publication Date(Web):
DOI:10.1002/cphc.201100578
Abstract
Gold-surface grafted peptide nucleic acid (PNA) strands, which carry a redox-active ferrocene tag, present unique tools to electrochemically investigate their mechanical bending elasticity based on the kinetics of electron-transfer (ET) processes. A comparative study of the mechanical bending properties and the thermodynamic stability of a series of 12-mer Fc-PNA⋅DNA duplexes was carried out. A single basepair mismatch was integrated at all possible strand positions to provide nanoscopic insights into the physicochemical changes provoked by the presence of a single basepair mismatch with regard to its position within the strand. The ET processes at single mismatch Fc-PNA⋅DNA modified surfaces were found to proceed with increasing diffusion limitation and decreasing standard ET rate constants k0 when the single basepair mismatch was dislocated along the strand towards its free-dangling Fc-modified end. The observed ET characteristics are considered to be due to a punctual increase in the strand elasticity at the mismatch position. The kinetic mismatch discrimination with respect to the fully-complementary duplex presents a basis for an electrochemical DNA sensing strategy based on the Fc-PNA⋅DNA bending dynamics for loosely packed monolayers. In a general sense, the strand elasticity presents a further physicochemical property which is affected by a single basepair mismatch which may possibly be used as a basis for future DNA sensing concepts for the specific detection of single basepair mismatches.
Co-reporter:Annika Gross, Merja Neukamm and Nils Metzler-Nolte
Dalton Transactions 2011 vol. 40(Issue 6) pp:1382-1386
Publication Date(Web):23 Dec 2010
DOI:10.1039/C0DT01113D
Organometallic conjugates of receptor-targeting peptides are proposed as interesting candidates for novel cancer therapies since they are capable of targeting a specific kind of cell. Here, we have synthesised a dicobalt hexacarbonyl alkyne compound linked to the neurotensin peptide hormone. In order to circumvent synthetic difficulties encountered when adding a cobalt carbonyl moiety onto the hydrophilic alkyne peptide, and to enhance the cellular uptake we functionalised the alkyne neurotensin(8–13) fragment (NT) first N-terminally by ruthenocene carboxylic acid to form the metallocene-alkyne-NT conjugate 3, before adding Co2(CO)8 to a propargyl glycine residue to form the Co-alkyne derivative 4. Compound 4 represents the first heterobimetallic organometallic peptide conjugate reported to date. It shows moderate cytotoxicity against HeLa, PT45 and HepG2 cell lines.
Co-reporter:Dr. Nina Hüsken;Dr. Magdalena G&x119;bala;Dr. Fabio LaMantia;Dr. Wolfgang Schuhmann;Dr. Nils Metzler-Nolte
Chemistry - A European Journal 2011 Volume 17( Issue 35) pp:9678-9690
Publication Date(Web):
DOI:10.1002/chem.201003764
Abstract
N-Terminally ferrocenylated and C-terminally gold-surface-grafted peptide nucleic acid (PNA) strands were exploited as unique tools for the electrochemical investigation of the strand dynamics of short PNA(⋅DNA) duplexes. On the basis of the quantitative analysis of the kinetics and the diffusional characteristics of the electron-transfer process, a nanoscopic view of the Fc-PNA(⋅DNA) surface dynamics was obtained. Loosely packed, surface-confined Fc-PNA single strands were found to render the charge-transfer process of the tethered Fc moiety diffusion-limited, whereas surfaces modified with Fc-PNA⋅DNA duplexes exhibited a charge-transfer process with characteristics between the two extremes of diffusion and surface limitation. The interplay between the inherent strand elasticity and effects exerted by the electric field are supposed to dictate the probability of a sufficient approach of the Fc head group to the electrode surface, as reflected in the measured values of the electron-transfer rate constant, k0. An in-depth understanding of the dynamics of surface-bound PNA and PNA⋅DNA strands is of utmost importance for the development of DNA biosensors using (Fc-)PNA recognition layers.
Co-reporter:Nina Hüsken;Magdalena G&x119;bala;Wolfgang Schuhmann Dr. Dr.
ChemBioChem 2010 Volume 11( Issue 12) pp:1754-1761
Publication Date(Web):
DOI:10.1002/cbic.200900748
Abstract
A Fc–PNA biosensor (Fc: ferrocenyl, C10H9Fe) was designed by using two electrochemically distinguishable recognition elements with different molecular information at a single electrode. Two Fc–PNA capture probes were therefore synthesized by N-terminal labeling different dodecamer PNA sequences with different ferrocene derivatives by click chemistry. Each of the two strands was thereby tethered with one specific ferrocene derivative. The two capture probes revealed quasi-reversible redox processes of the Fc0/+ redox couple with a significant difference in their electrochemical half-wave potentials of ΔE1/2=160 mV. A carefully designed biosensor interface, consisting of a ternary self-assembled monolayer (SAM) of the two C-terminal cysteine-tethered Fc–PNA capture probes and 6-mercaptohexanol, was electrochemically investigated by square wave (SWV) and cyclic voltammetry (CV). The biosensor properties of this interface were analyzed by studying the interaction with DNA sequences that were complementary to either of the two capture probes by SWV. Based on distinct changes in both peak current and potential, a parallel identification of these two DNA sequences was successful with one interface design. Moreover, the primary electrochemical response could be converted by a simple mathematical analysis into a clear-cut electrochemical signal about the hybridization event. The discrimination of single-nucleotide polymorphism (SNP) was proven with a chosen single-mismatch DNA sequence. Furthermore, experiments with crude bacterial RNA confirm the principal suitability of this dual-potential sensor under real-life conditions.
Co-reporter:Nina Hüsken, Gilles Gasser, S. David Köster and Nils Metzler-Nolte
Bioconjugate Chemistry 2009 Volume 20(Issue 8) pp:1578
Publication Date(Web):July 8, 2009
DOI:10.1021/bc9001272
The scope of the Cu(I)-catalyzed [2 + 3] azide/alkyne cycloaddition (CuAAC, click chemistry) as a key reaction for the conjugation of ferrocene derivatives to N-terminal functionalized PNA oligomers is explored herein (PNA: peptide nucleic acid). The facile solid-phase synthesis of N-terminal azide or alkyne-functionalized PNA oligomer precursors and their cycloaddition with azidoferrocene, ethynylferrocene, and N-(3-ethylpent-1-yn-3-yl)ferrocene-carboxamide (DEPA−ferrocene) on the solid phase are presented. While the click reaction with azidomethylferrocene worked equally well, the ferrocenylmethyl group is lost from the conjugate upon acid cleavage. However, the desired product was obtained via a post-SPPS conversion of the alkyne−PNA oligomer with azidomethylferrocene in solution. The synthesis of all ferrocene−PNA conjugates (trimer t3-PNA, 3, 4, 5, 6; 12mer PNA, 10 - t c t a c a a g a c t c, 11 - t c t a c c g t a c t c) succeeded with excellent yields and purities, as determined by mass spectrometry and HPLC. Electrochemical studies of the trimer Fc−PNA conjugates 3, 4, 5, and 6 with four different ferrocene moieties revealed quasi-reversible redox processes of the ferrocenyl redox couple Fc0/+ and electrochemical half-wave potentials in a range of E1/2 = −20 mV to +270 mV vs FcH0/+ (Fc: ferrocenyl, C10H9Fe). The observed potential differences ΔE1/2min are always greater than 60 mV for any given pair of Fc−PNA conjugates, thus allowing a reliable differentiation with sensitive electrochemical methods like e.g. square wave voltammetry (SWV). This is the electrochemical equivalent of “four-color” detection and is hence denoted “four-potential” labeling. Preparation and electrochemical investigation of the set of four structurally different and electrochemically distinguishable ferrocenyl groups conjugated to PNA oligomers, as exemplified by the conjugates 3, 4, 5, and 6, demonstrates the scope of the azide/alkyne cycloaddition for the labeling of PNA with electrochemically active ferrocenyl groups. Furthermore, it provides a PNA-based system for the electrochemical detection of single-nucleotide polymorphism (SNP) in DNA/RNA.
Co-reporter:Annika Gross, Nils Metzler-Nolte
Journal of Organometallic Chemistry 2009 694(7–8) pp: 1185-1188
Publication Date(Web):
DOI:10.1016/j.jorganchem.2008.09.071
Co-reporter:Fozia Noor Dr.;Ralf Kinscherf Dr.;Gabriel A. Bonaterra Dr.;Steffen Walczak;Stefan Wölfl Dr. Dr.
ChemBioChem 2009 Volume 10( Issue 3) pp:493-502
Publication Date(Web):
DOI:10.1002/cbic.200800469
Co-reporter:Antonio Pinto;Ulrich Hoffmanns Dr.;Melanie Ott;Gert Fricker Dr. Dr.
ChemBioChem 2009 Volume 10( Issue 11) pp:1852-1860
Publication Date(Web):
DOI:10.1002/cbic.200900157
Abstract
Enkephalin peptides are thought to be suitable vectors for the passage of the blood–brain barrier (BBB). Modifications that do not alter the amino acid sequence are often used to improve the permeation through living membrane systems. As a new type of modification we introduce organometallic compounds, in particular ferrocene carboxylic acid. Derivatives of [Leu5]enkephalin were synthesised and labelled with organometallic compounds by using solid-phase synthesis techniques. All new metal–peptide bioconjugates were comprehensively characterised by HPLC, NMR spectroscopy and mass spectrometry and found to be at least 95 % pure. For the first time, permeation coefficients in a BBB model for organometal–peptide derivatives were determined in this work. The uptake and localisation of fluorescein-labelled enkephalins was monitored by fluorescence microscopy on three cancer cell lines. Octanol/H2O partition coefficients of the compounds were measured by HPLC. The introduction of the organometallic moiety enhances the uptake into cells and the permeation coefficient of [Leu5]-enkephalin. This could be due to an increase in lipophilicity caused by the organometallic label. The metal–peptide conjugates were found to be nontoxic up to mM concentrations. The low cytotoxicity encourages further experiments that could take advantage of the selectivity of enkephalin derivatives for opioid receptors.
Co-reporter:SreckoI. Kirin Dr.;Ingo Ott Dr.;Ronald Gust Dr.;Walter Mier Dr.;Thomas Weyhermüller Dr. Dr.
Angewandte Chemie International Edition 2008 Volume 47( Issue 5) pp:955-959
Publication Date(Web):
DOI:10.1002/anie.200703994
Co-reporter:SreckoI. Kirin Dr.;Ingo Ott Dr.;Ronald Gust Dr.;Walter Mier Dr.;Thomas Weyhermüller Dr. Dr.
Angewandte Chemie 2008 Volume 120( Issue 5) pp:969-973
Publication Date(Web):
DOI:10.1002/ange.200703994
Co-reporter:Srećko I. Kirin, Heinz-Bernhard Kraatz and Nils Metzler-Nolte
Chemical Society Reviews 2006 vol. 35(Issue 4) pp:348-354
Publication Date(Web):23 Jan 2006
DOI:10.1039/B511332F
Ferrocene peptide conjugates display an array of structural features including helical ferrocene based chirality and a number of different intramolecular hydrogen bonding patterns. In this tutorial review we present a rigorous nomenclature for these systems, followed by a section that summarises and categorises the structures known to date. The issues discussed herein are of general relevance for all metallocene-based chiral transition metal catalysts and peptide turn mimetics.
Co-reporter:Ramin Hamzavi, Christoph Meyer and Nils Metzler-Nolte
Organic & Biomolecular Chemistry 2006 vol. 4(Issue 19) pp:3648-3651
Publication Date(Web):17 Aug 2006
DOI:10.1039/B607463D
Backbone modification of peptide nucleic acids (PNAs) by glycosylation has been shown to enhance selective biodistribution and cellular targeting of PNA oligomers based on sugar and cell surface lectin interactions. Here we report the synthesis of a new backbone-glycosylated thymine-based PNA monomer (Tgal). The sugar residue was attached to the backbone of PNA via a stable carbon–carbon linkage between the sugar and the PNA monomers. Also, incorporation of the modified monomer into a PNA decamer (H-Alagal-G-G-G-Tgal-C-A-G-C-Tgal-T-Lys-NH2) was successfully performed. Melting temperature (UV-Tm) of the modified PNA against the complementary DNA was only slightly lower than unmodified PNA.
Co-reporter:Ulrich Schatzschneider Dr. Dr.
Angewandte Chemie 2006 Volume 118(Issue 10) pp:
Publication Date(Web):2 FEB 2006
DOI:10.1002/ange.200504604
Metallische Kandidaten: Jüngste strukturelle und spektroskopische Untersuchungen belegen die Vielseitigkeit metallorganischer Wirkstoffe, z. B. als neuartige Proteinkinase-Inhibitoren und als Prodrugs gegen hormonunabhängige Brusttumoren. Das Übergangsmetallzentrum ermöglicht dabei sowohl die Positionierung der Liganden im Raum (siehe Bild) wie auch die Steuerung von Redoxaktivierungsprozessen in biologischen Systemen.
Co-reporter:Ulrich Schatzschneider,Nils Metzler-Nolte
Angewandte Chemie International Edition 2006 45(10) pp:1504-1507
Publication Date(Web):
DOI:10.1002/anie.200504604
Co-reporter:Annika Gross, Merja Neukamm and Nils Metzler-Nolte
Dalton Transactions 2011 - vol. 40(Issue 6) pp:NaN1386-1386
Publication Date(Web):2010/12/23
DOI:10.1039/C0DT01113D
Organometallic conjugates of receptor-targeting peptides are proposed as interesting candidates for novel cancer therapies since they are capable of targeting a specific kind of cell. Here, we have synthesised a dicobalt hexacarbonyl alkyne compound linked to the neurotensin peptide hormone. In order to circumvent synthetic difficulties encountered when adding a cobalt carbonyl moiety onto the hydrophilic alkyne peptide, and to enhance the cellular uptake we functionalised the alkyne neurotensin(8–13) fragment (NT) first N-terminally by ruthenocene carboxylic acid to form the metallocene-alkyne-NT conjugate 3, before adding Co2(CO)8 to a propargyl glycine residue to form the Co-alkyne derivative 4. Compound 4 represents the first heterobimetallic organometallic peptide conjugate reported to date. It shows moderate cytotoxicity against HeLa, PT45 and HepG2 cell lines.